Peanut lipidomic signature
Biomarker1 paper2 findings
- Human trial1
Effects
1Cardiovascular disease
no changein humans1HR 1.01
1 study
Cardiovascular disease
no changein humans1HR 1.01
Peanut lipidomic signature has no effect on cardiovascular disease in humans (HR 1.01, 95% CI 0.90–1.15).
Humansper 1-standard deviation increase in PeLS
Peanuts-derived plasma lipids and lower risk of type 2 diabetes: association mediated by body mass index-an intervention and case-cohort study · The American journal of clinical nutrition · 17 Sep 2026
Associations
1Type 2 diabetes
downin humans1HR 0.89
1 study
Type 2 diabetes
downin humans1HR 0.89
Peanut lipidomic signature lowers the risk of type 2 diabetes in humans (HR 0.89, 95% CI 0.80–0.99).
Humansper 1-standard deviation increase in PeLS
Peanuts-derived plasma lipids and lower risk of type 2 diabetes: association mediated by body mass index-an intervention and case-cohort study · The American journal of clinical nutrition · 17 Sep 2026